Erlotinib Prevention of Oral Cancer (EPOC)
Clinical trial NCT00402779 · COMPLETED
Trial details
- NCT number
- NCT00402779
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-03
- Primary completion
- 2018-06-04
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.